LANE DUDO: Open Payments
NPI 1164994430 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,120 in 57 payments from 9 companies in 2025. Trend: 2023 $998 · 2024 $1,235 · 2025 $2,120
Food & beverage: $2,120
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $978 |
| Madrigal Pharmaceuticals | 5 | $294 |
| GENZYME CORPORATION | 5 | $267 |
| Janssen Scientific Affairs, LLC | 2 | $200 |
| Phathom Pharmaceuticals, Inc. | 4 | $128 |
| Janssen Biotech, Inc. | 1 | $111 |
| Ardelyx, Inc. | 1 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $16 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, DUPIXENT, CREON, LINZESS, VOQUEZNA, IBSRELA.
Industry payments across TX — which companies pay providers there.
